Morganna Freeman, DO, FACP from The Angeles Clinic and Research Institute points out the need for early detection and intervention with many of the side effects seen from immunotherapy treatments.
Using colitis as an example, Freeman discusses what could happen if adverse events go unattended. This could result in long-term hospitalization or more severe medication for the patient. However, earlier reporting and intervention could prevent even hospitalization.
Patients With uHCC Who Experience irAEs With Tremelimumab/Durvalumab Achieve Numerical Improvements in OS
Adding Ribociclib to Endocrine Therapy Yields 25% Relative Reduction in Risk of Invasive Disease In Patients With HR+/HER2– Early Breast Cancer
Simple Hysterectomy May Replace Radical Hysterectomy as Standard of Care in Low-Risk, Early-Stage Cervical Cancer
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis
2 Clarke Drive
Cranbury, NJ 08512